Clinical Trial Update: The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

The Phase 3 'VISION' trial evaluating Ventavis (iloprost) inhalation with sildenafil for pulmonary arterial hypertension was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)
• Ventavis (iloprost)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2010-08-13